Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,6589,178,4.76 [1.96-11.59],0.0005787731414674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,7543,206,0.72 [0.57-0.91],0.0058978502581246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,7486,206,1.60 [1.01-2.53],0.0454305531983454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,6435,173,0.51 [0.32-0.80],0.0037839738800684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,6368,169,0.81 [0.70-0.94],0.0047141547283159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",7455,202,1.32 [1.03-1.70],0.0299518550300304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,6368,169,1.60 [1.09-2.34],0.0154738956419247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,6393,171,1.91 [1.02-3.58],0.0425582444076027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,6435,173,0.80 [0.65-0.98],0.0329959479305792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,6553,176,1.29 [1.00-1.67],0.048110244044605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,7605,207,1.55 [1.03-2.36],0.0378521248087793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,7572,207,1.85 [1.17-2.94],0.0087579866164001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFM,Afamin,6589,178,2.07 [1.02-4.19],0.0432783440595579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,7562,207,1.43 [1.07-1.91],0.0164962896726649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,7571,208,0.81 [0.70-0.94],0.0067766619297047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,7681,210,2.34 [1.29-4.25],0.0050232953864088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,7592,208,0.71 [0.55-0.92],0.0081918498338149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,7648,207,2.52 [1.41-4.49],0.0017323373254589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,7422,204,1.20 [1.00-1.44],0.0454122489697654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,6567,172,0.78 [0.64-0.96],0.020296647190114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,7598,204,1.52 [1.06-2.18],0.0215463716108813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,7611,206,1.59 [1.04-2.43],0.0337064659523569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,7437,205,0.71 [0.54-0.93],0.0131383131096069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,6400,169,1.22 [1.01-1.46],0.034701251546664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,6592,177,1.80 [1.08-2.98],0.0233912203510251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,7437,205,0.74 [0.59-0.93],0.0089455217346837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,6567,172,0.79 [0.62-1.00],0.0494413537179738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,7623,207,2.05 [1.32-3.18],0.001317362991341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",7605,207,1.66 [1.08-2.56],0.0206351463232155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,7437,205,1.90 [1.29-2.78],0.0010450474152009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,7592,208,0.80 [0.66-0.97],0.0262820311497706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,6393,171,0.72 [0.54-0.95],0.0219910163607427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,6565,176,1.29 [1.04-1.60],0.0209335595542694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,7422,204,1.35 [1.03-1.76],0.0307314444912338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,6400,169,1.48 [1.11-1.97],0.0082610748402921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,7605,207,1.74 [1.13-2.67],0.0110904236377145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,6570,178,3.31 [1.54-7.09],0.0021268666637231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,6589,178,2.69 [1.46-4.95],0.0015213251378514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2,Complement C2,7611,206,2.96 [1.55-5.64],0.0009882486961724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,7412,204,1.39 [1.09-1.79],0.0090362136530653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,7608,208,1.63 [1.20-2.23],0.0019496528428073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,6553,176,0.82 [0.68-0.98],0.0326189341014262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,7442,202,0.72 [0.58-0.90],0.0036040795767327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,7543,206,1.47 [1.03-2.11],0.0345492102264934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,7563,208,0.78 [0.64-0.94],0.0077361786278428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,7673,210,0.73 [0.58-0.90],0.0041072563598798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,7572,208,0.75 [0.61-0.91],0.0035951086782288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,6413,172,1.43 [1.07-1.92],0.0152756029327924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,7545,206,2.06 [1.12-3.78],0.0198898779932404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,7422,204,0.70 [0.54-0.91],0.0069775602963217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,7422,204,1.23 [1.05-1.44],0.0105560905572167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAT,Catalase,6498,176,0.72 [0.54-0.96],0.0244194223402713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,7578,204,1.71 [1.32-2.22],5.113526388529831e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,7488,201,1.18 [1.00-1.38],0.0473229082274526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,7506,207,1.35 [1.08-1.69],0.0089227820667788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,7605,207,1.38 [1.02-1.85],0.033921176464377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,7668,210,1.99 [1.45-2.73],2.231531368066802e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,7452,202,1.61 [1.20-2.17],0.0014894631396938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,7660,209,1.33 [1.04-1.70],0.0248679170854169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,7623,207,1.40 [1.06-1.84],0.0184727823250816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,7608,208,2.43 [1.46-4.05],0.0006449196352834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,7551,209,1.56 [1.12-2.18],0.0085223995545319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,7660,209,1.63 [1.07-2.49],0.0243565347194647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,7437,205,1.42 [1.05-1.92],0.0243374051967145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,7635,206,1.38 [1.04-1.82],0.0243956745447282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,7659,207,1.42 [1.13-1.77],0.0022465117465278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,7543,206,1.46 [1.01-2.12],0.0460449385187964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,7555,204,1.62 [1.07-2.43],0.0213140375971251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,7598,207,1.58 [1.06-2.37],0.0258610924894513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,7562,207,2.07 [1.03-4.19],0.0424420743001363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,6580,177,1.76 [1.18-2.63],0.0056749517556801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,7573,209,1.49 [1.05-2.10],0.0253912116581291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,6553,176,1.92 [1.21-3.06],0.0059352070299022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,7641,209,1.33 [1.06-1.66],0.0134635373283349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,7324,197,1.67 [1.13-2.45],0.0092456249539842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,7335,201,1.54 [1.19-2.00],0.0012035327119401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,7572,207,1.55 [1.11-2.18],0.0103486582248658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,6553,176,0.64 [0.45-0.92],0.0146549089409311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,6476,173,1.75 [1.11-2.76],0.0159980752149779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,6209,161,2.19 [1.14-4.21],0.0192831964278576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,6576,177,1.31 [1.06-1.63],0.0128799000290872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,6589,178,2.93 [1.39-6.17],0.0047786972742295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFP,Properdin,6589,178,2.07 [1.33-3.22],0.001169855143107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,7592,208,1.43 [1.21-1.69],3.181375334169737e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,6413,172,1.47 [1.07-2.03],0.0188327316975521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,7437,205,0.79 [0.63-0.99],0.0434324292472418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,6573,174,0.76 [0.58-0.98],0.0348966030585679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,7455,202,1.53 [1.08-2.17],0.0171823643347117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,7573,209,1.61 [1.11-2.32],0.0118612881000669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,6413,172,1.61 [1.25-2.08],0.0002498472460435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,7659,207,1.89 [1.12-3.19],0.0165336730372722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,6413,172,0.53 [0.33-0.85],0.0082994004409686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,7660,209,0.67 [0.48-0.94],0.0213002338474897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,7623,207,1.44 [1.08-1.92],0.0123785181945965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,6400,169,1.37 [1.11-1.67],0.0027348756358043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,7681,210,1.75 [1.07-2.87],0.0263512441541509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,7681,210,1.41 [1.03-1.91],0.0294030609607996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,6448,175,0.54 [0.36-0.81],0.0034381544904638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,7573,207,1.67 [1.09-2.56],0.0188439734418619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,6579,178,2.51 [1.32-4.77],0.0049656577684404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,6580,177,1.85 [1.08-3.17],0.0242049456470442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,6570,177,1.54 [1.03-2.29],0.0332325847848271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,7573,207,2.34 [1.48-3.68],0.0002458028518511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,7605,207,1.77 [1.08-2.92],0.0240266660902108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,7605,207,1.98 [1.28-3.05],0.0020154220557369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,6354,169,0.82 [0.69-0.98],0.0249770375689331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,7610,207,1.54 [1.04-2.28],0.032106999370549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,7385,206,0.64 [0.50-0.82],0.0003314262860652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,7585,207,1.14 [1.01-1.27],0.0279671185917609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,7421,202,1.22 [1.03-1.44],0.0209612751899173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,7572,207,1.63 [1.00-2.64],0.049468350401332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,7455,203,0.69 [0.50-0.96],0.0279904016633806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,7660,209,1.46 [1.11-1.92],0.0074965858199852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",7493,207,0.82 [0.69-0.97],0.0216058435266366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,6435,173,0.77 [0.63-0.93],0.0082480561201657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,6400,169,1.29 [1.01-1.65],0.0390683854736159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,7660,209,0.81 [0.67-0.99],0.0420869481009607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,7608,208,2.09 [1.44-3.02],9.58721408237402e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,6567,172,0.75 [0.61-0.92],0.0068515134012362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,6435,173,0.70 [0.52-0.93],0.0153283442291432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,7632,206,1.23 [1.02-1.49],0.0338655248450908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,6413,172,0.74 [0.57-0.97],0.0288261953484247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,7455,202,1.59 [1.14-2.21],0.005669265107068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,7582,208,1.72 [1.18-2.51],0.0048203102336054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,7572,207,0.76 [0.62-0.93],0.0090930742608893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELN,Elastin,6580,177,1.63 [1.09-2.45],0.0181365307079264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,6068,167,0.69 [0.53-0.90],0.0058474827958073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,7681,210,1.70 [1.06-2.73],0.0274632390058488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,6393,171,0.75 [0.56-0.99],0.0430265684471743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,7594,207,1.61 [1.07-2.42],0.021911287623284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,7323,196,1.86 [1.31-2.64],0.0005042113308759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,7681,210,1.79 [1.15-2.79],0.0102132408528016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,7553,207,2.71 [1.53-4.78],0.0005993300322007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,7608,208,1.68 [1.01-2.82],0.0465094526301502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,6592,177,1.53 [1.07-2.19],0.0213188124993029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,6500,176,2.00 [1.41-2.83],9.639607226016742e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,6589,178,1.46 [1.00-2.12],0.0485502283068836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,6564,178,1.96 [1.10-3.50],0.0232946513018781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,6589,178,3.04 [1.15-8.05],0.0254475508019866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,7614,207,2.37 [1.56-3.61],4.9297691506020745e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,7611,206,2.58 [1.33-5.03],0.0051858290147718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,7573,209,0.66 [0.53-0.84],0.0004554247915287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,6580,177,1.24 [1.01-1.51],0.0371931095341029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,7603,207,1.39 [1.07-1.81],0.0150494475470962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,7562,202,1.47 [1.06-2.05],0.0217208286162915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,7572,207,1.42 [1.09-1.86],0.0100634366815212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,7611,206,3.81 [2.48-5.85],1.066341723006909e-09
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,7608,208,1.59 [1.09-2.33],0.0171495134949841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,7641,209,1.80 [1.19-2.73],0.0056628366200456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,6393,171,1.50 [1.15-1.96],0.0027267366776365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,7605,207,0.78 [0.65-0.95],0.0119366714571863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,7543,206,1.93 [1.05-3.56],0.0347257033478705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,6448,175,1.36 [1.11-1.66],0.0025536739376298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,6354,169,1.57 [1.12-2.21],0.0095839898580017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,6350,168,0.55 [0.31-0.98],0.0407992980868365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,6589,178,1.97 [1.14-3.41],0.0158744805371896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,7572,207,1.78 [1.26-2.51],0.0009842778248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,7647,207,2.08 [1.42-3.04],0.000182211506447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,7467,205,1.61 [1.13-2.28],0.0076534166716992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,7525,205,0.79 [0.63-1.00],0.0462772241157131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,7660,209,0.78 [0.61-0.99],0.0453110590245089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,7641,209,1.66 [1.06-2.59],0.0257479357346823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",6573,174,0.59 [0.41-0.87],0.0077646408011384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,7569,203,1.54 [1.07-2.21],0.0188885843605406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,6553,176,1.37 [1.03-1.80],0.0279431543295517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,7422,204,1.41 [1.01-1.96],0.0446501702226576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",7636,207,0.77 [0.64-0.92],0.0037504226210845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,7648,207,1.30 [1.08-1.55],0.0052030730707413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,7592,208,1.50 [1.08-2.08],0.0152165111723469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,7659,207,0.80 [0.66-0.99],0.0365879785762159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,6368,169,0.68 [0.49-0.94],0.0208921260877278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",7573,209,1.54 [1.05-2.26],0.0266796173613162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,7659,207,0.66 [0.49-0.88],0.0051452297689478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,6400,169,1.36 [1.03-1.79],0.0304636780619293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,7681,210,2.12 [1.28-3.53],0.0037466435822003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,7565,203,1.74 [1.16-2.62],0.0080180324813207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,7681,210,1.52 [1.04-2.22],0.0295132156689975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,7605,207,2.00 [1.19-3.36],0.0086680870615913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,7543,206,1.71 [1.04-2.80],0.0343116797249434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,7623,207,2.65 [1.76-3.98],2.952737131050063e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,7495,203,1.30 [1.02-1.67],0.0352277193944704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,7605,207,1.65 [1.14-2.41],0.0087849874742543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,7455,203,1.46 [1.05-2.03],0.0246354713376322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,7499,206,2.17 [1.29-3.62],0.0032823836306913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,7592,208,1.40 [1.06-1.86],0.0187607830106779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,7623,207,1.77 [1.23-2.55],0.0021174378973406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,7582,208,2.10 [1.27-3.45],0.00353950949658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,7592,208,1.34 [1.04-1.74],0.0260409610957094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,7661,210,0.70 [0.54-0.91],0.0080293115070118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,7530,209,1.39 [1.04-1.86],0.0275246513067802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,7558,203,1.52 [1.06-2.19],0.0245651560627279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,6567,172,0.74 [0.56-0.97],0.0299226968520484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,6567,172,0.70 [0.60-0.81],3.221058113594795e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,6554,173,0.62 [0.42-0.91],0.0144033688032075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,7573,209,0.65 [0.45-0.93],0.0182842338490753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,7659,207,1.30 [1.01-1.68],0.0432314570368809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,7623,207,1.48 [1.06-2.06],0.0216339865456129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,6589,178,2.36 [1.38-4.03],0.001717799667473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,7641,209,1.55 [1.02-2.36],0.0410038423190071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,7608,208,3.02 [1.81-5.02],2.0796049977585423e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,7611,206,1.53 [1.01-2.32],0.0459417503717796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,6571,175,0.64 [0.45-0.91],0.0133676188922526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,6540,173,1.39 [1.06-1.82],0.0176573170799067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,6573,174,0.42 [0.36-0.48],6.62496838725625e-35
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,7659,207,1.44 [1.24-1.69],3.975482077919954e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,6447,175,2.82 [1.52-5.23],0.0010340696707408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,7660,209,1.44 [1.06-1.95],0.0188612538888063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,6400,169,1.27 [1.05-1.53],0.0128016561377199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,6567,172,1.46 [1.11-1.91],0.006747030090977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,7561,207,0.77 [0.61-0.98],0.0303851909796558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,7573,207,1.35 [1.01-1.81],0.0423394751303778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,7605,207,1.53 [1.08-2.18],0.0168665923035966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,7346,201,2.38 [1.27-4.45],0.0066789775138097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,7623,207,1.39 [1.13-1.72],0.0019611284864025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,7611,210,1.41 [1.11-1.80],0.0047803867305649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,6580,177,1.36 [1.09-1.68],0.0054445837397457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEP,Leptin,7572,207,1.45 [1.21-1.75],5.523711562410815e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,6589,178,1.83 [1.23-2.73],0.0029721761680456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,7578,207,1.54 [1.05-2.25],0.0281366955006231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,7581,207,0.78 [0.64-0.96],0.0163739599406284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,7592,208,1.50 [1.05-2.14],0.0249877719301904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,7561,206,1.71 [1.17-2.50],0.0056621759257534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,7681,210,1.75 [1.12-2.74],0.0147492099128531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,7649,209,1.59 [1.10-2.31],0.0140469749847568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,6393,171,1.27 [1.01-1.60],0.0385986364626708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,6567,172,1.95 [1.29-2.95],0.0016135232111958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,7543,206,1.41 [1.08-1.86],0.0127214166855851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,6553,176,1.65 [1.18-2.30],0.0033166674633428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LXN,Latexin,7472,207,0.78 [0.65-0.95],0.0136733603187532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,6589,178,2.86 [1.43-5.70],0.0029375903031731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,7681,210,0.74 [0.59-0.94],0.0130775503019859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,6497,174,1.15 [1.00-1.32],0.0452569699696277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,7647,207,0.80 [0.64-0.99],0.0443353591991618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,7543,206,0.82 [0.69-0.97],0.0228906206779155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,7602,206,1.29 [1.04-1.59],0.0180358750150005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,7422,204,1.60 [1.10-2.34],0.0147215764634583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,7592,208,0.64 [0.49-0.82],0.0005172431653158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",7422,204,1.58 [1.11-2.24],0.0112140319593463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,7586,204,0.51 [0.43-0.60],8.128108310476567e-16
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,7641,209,1.35 [1.04-1.76],0.0241923245431622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,7608,208,1.59 [1.03-2.46],0.0351458443218346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,6553,176,1.46 [1.00-2.13],0.0486027790203971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,7608,208,1.63 [1.18-2.25],0.0029152079421136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,7592,208,1.72 [1.00-2.96],0.0481678961631103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,7681,210,2.88 [1.37-6.05],0.0053436694647722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,6573,174,0.39 [0.25-0.59],1.3147338906594254e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,7592,208,1.69 [1.10-2.57],0.0153950997544163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,7572,207,0.88 [0.79-0.98],0.0211943598430742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],7543,206,0.79 [0.62-1.00],0.0483057984196412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,7481,206,0.78 [0.63-0.95],0.0163480058754333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,7592,208,1.61 [1.24-2.09],0.0003597536436005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,7543,206,0.79 [0.66-0.95],0.0114149813873773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,6560,176,2.75 [1.39-5.43],0.0036910564065576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,7632,207,2.44 [1.31-4.54],0.0050770584304253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,7592,208,2.16 [1.34-3.49],0.0014886092201604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,7455,203,0.76 [0.58-0.99],0.0453690962201856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,6350,168,1.28 [1.02-1.61],0.032192151399031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,7437,205,1.77 [1.12-2.79],0.0143848790884214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,7573,209,0.80 [0.65-0.99],0.0365505259697723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,6368,169,0.73 [0.53-1.00],0.0473486821831154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,7587,207,0.77 [0.63-0.93],0.0085625629783583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",6567,172,0.72 [0.56-0.91],0.0073210103460125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,6413,172,1.39 [1.10-1.75],0.0055539330809282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,6368,169,0.63 [0.44-0.90],0.0118118760886834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,7543,206,0.68 [0.55-0.84],0.0002943936169538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,7437,205,1.36 [1.17-1.59],9.593308543754398e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,7350,205,0.82 [0.70-0.95],0.0089713740316837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,6471,173,0.75 [0.59-0.97],0.0252125760514644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,6567,172,1.75 [1.33-2.30],6.612415654612457e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,7611,206,2.87 [1.76-4.68],2.515267797568897e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,7573,209,0.64 [0.50-0.83],0.0006893648938154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,6589,178,1.80 [1.04-3.10],0.0347916013438818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,7543,206,0.76 [0.60-0.96],0.0233210805879945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,7471,203,0.65 [0.46-0.94],0.0203953300257819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,7573,209,0.73 [0.57-0.94],0.0147838871694367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,7681,210,1.72 [1.07-2.78],0.0255978458579663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,6589,178,1.68 [1.18-2.40],0.0042103786116345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,7422,204,1.25 [1.00-1.56],0.049514407951719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,7455,203,0.76 [0.61-0.96],0.0184919635840651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,7632,207,1.57 [1.25-1.96],7.555095145040087e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,7391,205,0.75 [0.60-0.93],0.0106996103730471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,7584,207,1.40 [1.12-1.75],0.0030143910482466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REN,Renin,7572,207,0.84 [0.73-0.98],0.0238528353009825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,7641,209,1.54 [1.06-2.25],0.0236209547896178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,7636,207,0.78 [0.63-0.96],0.0215663681855017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,6427,173,0.49 [0.36-0.68],1.3625738410380944e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,7641,209,1.81 [1.10-2.98],0.0202201992371122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,7437,205,1.27 [1.02-1.58],0.0333982090714927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,7659,207,1.62 [1.15-2.28],0.005483030822189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,7608,208,0.80 [0.64-1.00],0.04868829799626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,7584,207,1.44 [1.00-2.07],0.0479351140784033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,7573,209,0.63 [0.42-0.94],0.0238168401687948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,7572,207,1.87 [1.19-2.95],0.0065989213294382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,7681,210,1.55 [1.14-2.09],0.0048255478028877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,6571,178,2.89 [1.38-6.07],0.0049457067069431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,6479,176,1.71 [1.12-2.60],0.0133179299312734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,6589,178,3.03 [1.22-7.54],0.016977380901727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,7455,202,1.48 [1.14-1.93],0.0031822127370299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,6579,178,4.79 [1.92-11.94],0.0007928122765419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,6579,178,2.02 [1.22-3.36],0.0065057360595412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,6482,174,2.19 [1.30-3.68],0.0031324140470448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,6449,174,5.88 [2.10-16.46],0.0007323226973468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,6579,178,2.34 [1.08-5.07],0.0309154352340675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,7543,206,1.82 [1.14-2.92],0.0125849128042981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,7605,207,1.45 [1.09-1.94],0.010815509390455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,7573,209,1.56 [1.09-2.23],0.0140086301624388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,7422,204,1.20 [1.04-1.38],0.0126906456972359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,7659,207,1.37 [1.02-1.85],0.0359313844544336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,7455,202,1.65 [1.18-2.30],0.0031384386387572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,6553,176,0.59 [0.39-0.89],0.0127522392888818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,7623,207,0.76 [0.64-0.91],0.0022923723014172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,6553,176,0.76 [0.70-0.82],2.68091378098248e-12
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,7503,207,0.60 [0.37-0.96],0.0332896740725937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,7584,207,1.43 [1.00-2.05],0.048795765636826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,7623,207,1.59 [1.18-2.12],0.0020439324067314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",7681,210,1.65 [1.18-2.30],0.0033051209076909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,6553,176,0.66 [0.44-0.99],0.0468470523362049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,7422,204,0.63 [0.46-0.87],0.0047618527118299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,6413,172,0.64 [0.50-0.81],0.00027638684123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,7585,207,1.38 [1.03-1.84],0.0307059925649981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,7578,204,1.70 [1.25-2.32],0.0008289673319244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,7587,208,1.47 [1.16-1.86],0.0013458957482906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,7618,207,1.48 [1.09-2.02],0.0114034396491679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,6554,173,1.23 [1.08-1.39],0.0017228859828571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,7608,208,1.82 [1.34-2.47],0.0001279889187983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,7562,207,0.81 [0.69-0.96],0.0135219334605368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,7572,207,1.50 [1.03-2.19],0.0342863442926103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,7623,207,1.69 [1.27-2.23],0.000263141460575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,6368,169,1.67 [1.01-2.79],0.0471014215808492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,7584,207,1.46 [1.00-2.13],0.0479287870823587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,7592,208,1.54 [1.08-2.21],0.0183697891619819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,7592,208,1.35 [1.03-1.76],0.0284516626074732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,7641,209,1.77 [1.17-2.67],0.0069383807558744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,7648,209,1.44 [1.07-1.95],0.0167845572879773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,7503,207,1.57 [1.20-2.06],0.0011376522999022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,7660,209,1.93 [1.19-3.14],0.0082248871694997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,7670,210,1.95 [1.32-2.88],0.0007435045181148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,7503,207,1.47 [1.11-1.94],0.0076795678132484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,7573,209,0.76 [0.63-0.92],0.0051597717168705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,7573,207,1.42 [1.14-1.77],0.0017357050157607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,7573,209,0.84 [0.71-0.99],0.0398475096193755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,7455,202,0.43 [0.34-0.54],2.4592684074071368e-12
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,6388,168,1.16 [1.02-1.31],0.0216216997189221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,7572,207,1.68 [1.08-2.60],0.0204707318416674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,7543,206,0.64 [0.44-0.92],0.0178703067860268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,7503,207,1.50 [1.12-2.01],0.0060228020258786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,6413,172,0.77 [0.60-0.99],0.0415532118635529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,6567,172,1.41 [1.03-1.93],0.0329939544053713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,7468,203,1.98 [1.26-3.11],0.0032513658201654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,7611,206,1.60 [1.03-2.49],0.0357022171766701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,6350,168,1.19 [1.04-1.37],0.0119323390991771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,6554,173,1.25 [1.03-1.52],0.0228632866017603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,7455,202,1.21 [1.00-1.45],0.0443296505774893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,7437,205,2.35 [1.66-3.34],1.656093249770596e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,6350,168,0.77 [0.60-0.99],0.0423623236300776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,7478,206,1.45 [1.08-1.96],0.0150251170564172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,7647,207,0.74 [0.60-0.90],0.0030551365083409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,7207,196,1.33 [1.01-1.75],0.0400184344359502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,6354,169,0.71 [0.55-0.91],0.0065095831793005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,6350,168,0.46 [0.24-0.86],0.0149416411249255
